NNMT inhibitor (small-molecule research compound)
5-amino-1MQ
Inhibits nicotinamide N-methyltransferase, a metabolic that consumes nicotinamide and can influence salvage in experimental models.
Primary Mechanism of Action
Clinical / Scientific
5-amino-1-methylquinolinium inhibits NNMT, reducing methylation of nicotinamide. In adipocyte and metabolic models this can increase nicotinamide available for salvage and alter SAM-dependent methylation. Human therapeutic status is not established.
Pathway Targets
NNMT
Scientific explanation
inhibition in nicotinamide metabolism.
NAD+ salvage
Scientific explanation
Potential increase in precursor availability in models.
Pathway Convergence
Clinical / Scientific
Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.
Receptor to physiology
Target to downstream effect: NNMT → NAD+ salvage
Mechanistically Relevant Repurposed & Adjunctive Applications
Research peptide context
PreclinicalMechanistic rationale
Catalogued as a research peptide. Mechanistic statements below describe known or pathway biology and do not establish a licensed therapeutic indication.
Mechanistic Application Matrix
| Biological Target | Mechanism | Potential Relevance | Evidence Level |
|---|---|---|---|
| NNMT | Inhibition | NAD+ / methylation metabolism | Preclinical |
In Plain Language
5-amino-1MQ blocks an (NNMT) that uses up nicotinamide. In lab models that can leave more raw material for making , a cellular energy helper.
Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.